Table 1. Numbers of persons who took part in interviews or meetings by country and type of position.
Type of Position | India | Sri Lanka | Thailand | Vietnam | Brazil | Colombia | Mexico | Nicaragua | Total |
Senior government policymakers, program managers, department heads and other officials in health ministries and other health agencies | 10 | 12 | 6 | 10 | 4 | 6 | 6 | 7 | 61 |
Hospital directors and other representatives | 2 | 2 | 5 | 5 | 1 | – | 1 | 5 | 21 |
Scientists from research institutes and academia | 2 | 1 | 1 | 2 | 7 | 2 | 2 | 1 | 18 |
Officers from professional associationsa | 2 | – | – | – | 1 | 3 | 2c | 3 | 10 |
Local-level health policymakers and other officials (state, provincial, municipality) | 1 | 4 | – | – | 1 | – | 3 | 4 | 13 |
Representatives from local vaccine producers and multi-national pharmaceutical companiesb | 8 | – | – | 1 | 6 | 2 | 1 | – | 18 |
International agency officials (WHO, PAHO, UNICEF) | 7 | – | 1 | 3 | – | 1 | – | 1 | 13 |
National regulatory agency/laboratory officials | – | – | 1 | – | 1 | – | – | 1 | 3 |
Other | – | – | – | – | – | – | 1 | – | 1 |
Total number of informants | 32 | 19 | 14 | 21 | 21 | 14 | 15 | 22 | 158 |
Includes Presidents, General Secretaries and other top officials from national medical, pediatric, infectious disease and public health associations.
All were from local vaccine producers, except in Colombia, where representatives from Sanofi Pasteur were interviewed.
One of the professional society officials in Mexico was counted in another category and thus not included in the total.